Canada Markets closed

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.0000+0.0300 (+0.76%)
At close: 04:00PM EDT
4.1000 +0.10 (+2.50%)
After hours: 06:29PM EDT
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 322.9100
52 Week Low 33.0500
50-Day Moving Average 34.7053
200-Day Moving Average 39.4588

Share Statistics

Avg Vol (3 month) 3836.88k
Avg Vol (10 day) 31.02M
Shares Outstanding 5160.3M
Implied Shares Outstanding 6N/A
Float 8132.36M
% Held by Insiders 19.41%
% Held by Institutions 129.23%
Shares Short (Apr 28, 2022) 43.25M
Short Ratio (Apr 28, 2022) 43.98
Short % of Float (Apr 28, 2022) 42.57%
Short % of Shares Outstanding (Apr 28, 2022) 42.02%
Shares Short (prior month Mar 30, 2022) 42.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-590.52%

Management Effectiveness

Return on Assets (ttm)-28.61%
Return on Equity (ttm)-72.40%

Income Statement

Revenue (ttm)20.38M
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)20.38M
EBITDA -120.28M
Net Income Avi to Common (ttm)-167.81M
Diluted EPS (ttm)-3.9390
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)362.27M
Total Cash Per Share (mrq)2.25
Total Debt (mrq)743k
Total Debt/Equity (mrq)0.19
Current Ratio (mrq)17.92
Book Value Per Share (mrq)2.84

Cash Flow Statement

Operating Cash Flow (ttm)-63.25M
Levered Free Cash Flow (ttm)-15.6M